Companies Dominating the Medical Polyoxymethylene Market
- BASF SE
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Celanese Corporation,
- Polyplastics Co. Ltd,
- DuPont de Nemours Inc,
- Ensinger, Korea Engineering Plastics Co. Ltd,
- Mitsubishi Chemical Corporation,
- Westlake Plastics Company,
- Asahi Kasei Corporation,
- PolyOne Corporation
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of medical polyoxymethylene is assessed at USD 100.78 million.
The medical polyoxymethylene market size was valued at USD 95.87 million in 2024 and is set to reach USD 214.1 million by the end of 2037, expanding at around 6.5% CAGR during the forecast period i.e., between 2025-2037. The market growth is driven by growing prevalence of hospital care-associated infections (HCAIs), rise in use of pen insulin, surge in investment in medical devices industry, and others.
Asia Pacific industry is poised to dominate 38% revenue share by 2037, backed by upsurge in industrialization, and expanding healthcare sector in the region.
The major players in the market include BASF SE, Celanese Corporation, Polyplastics Co. Ltd, DuPont de Nemours Inc, Ensinger, Korea Engineering Plastics Co. Ltd, Mitsubishi Chemical Corporation, Westlake Plastics Company, Asahi Kasei Corporation, PolyOne Corporation.
